IP Library Granted Patent US 7,648,500
Granted Patent B2
US 7,648,500 · App. 11/175,471 · Granted Jan 19, 2010

Sphincter treatment apparatus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,648,500
App. No.
11/175,471
Granted
Jan 19, 2010
Kind
B2
Abstract

A sphincter treatment apparatus includes an energy delivery device introduction member including a proximal end with a first radius of curvature and a distal end with a second radius of curvature. The introduction member is configured to be introduced into the sphincter in a non-deployed state and to be expanded to a deployed state to at least partially expand the sphincter or an adjoining structure. An energy delivery device is coupled to the introduction member. A retainer member is coupled to the energy delivery device introduction member and configured to controllably position the introduction member in an orifice of the sphincter.

Claims (37)

1. A method of treating tissue regions at or near the lower esophageal sphincter comprising

providing an expandable structure carrying an energy delivery device comprising at least one tissue-piercing needle electrode sized and configured for deployment between a retracted position and an extended position, the structure having a non-deployed state and a deployed state,

introducing the structure while in the non-deployed state and with the at least one tissue-piercing needle electrode in the retracted position through an esophagus to a first tissue region comprising the cardia of the stomach,

expanding the structure to the deployed state in the first tissue region,

deploying the at least one tissue-piercing needle electrode to the extended position to pierce sub-mucosal tissue in the first tissue region,

delivering sufficient radio frequency energy from the at least one needle-piercing electrode to cause necrosis of the sub-mucosal tissue due to resistance heating to create a sub-mucosal lesion in the interior of the first tissue region,

moving the at least one tissue-piercing electrode to the retracted position,

collapsing the structure to the non-deployed state,

moving the structure while in the non-deployed state and with the at least one tissue-piercing needle electrode in the retracted position from the first tissue region to a second tissue region comprising the lower esophageal sphincter,

expanding the structure to the deployed state in the second tissue region,

deploying the at least one tissue-piercing needle electrode to the extended position to pierce sub-mucosal tissue in the second tissue region,

delivering sufficient radio frequency energy from the at least one needle-piercing electrode to cause necrosis of the sub-mucosal tissue due to resistance heating to create a sub-mucosal lesion in the interior of the second tissue region,

collapsing the structure to the non-deployed state,

moving the at least one tissue-piercing electrode to the retracted position, and

removing the structure from the esophagus, whereby a pattern of sub-mucosal lesions is formed in the first and second tissue regions to create a desired tissue effect.

2. A method according to claim 1

wherein the desired tissue effect includes a reduction in a duration of lower esophageal sphincter relaxation.

3. A method according to claim 1

wherein the desired tissue effect includes a reduction in a frequency of reflux of stomach contents into the esophagus.

4. A method according to claim 1

wherein the desired tissue effect includes a reduction of a frequency of a symptom of reflux of stomach contents into the esophagus.

5. A method according to of claim 1

wherein the desired tissue effect includes a reduction of an incidence of a sequela of reflux of stomach contents into the esophagus.

6. A method according to claim 1

wherein the desired tissue effect includes a tightening of the lower esophageal sphincter.

7. A method according to claim 1 , further comprising

introducing a fluid to at least one of the first and second tissue regions.

8. A method according to claim 1

wherein the desired tissue effect includes blocking of an electrical conduction pathway in at least one of the esophagus, the lower esophageal sphincter, and the cardia.

9. A method according to claim 1

wherein the desired tissue effect includes ablating an electrical pathway in at least one of the esophagus, the lower esophageal sphincter, and the cardia.

10. A method according to claim 1

wherein the desired tissue effect includes ablating an electrical foci in at least one of the esophagus, the lower esophageal sphincter, and the cardia.

11. A method according to claim 1

wherein the desired tissue effect includes inducing necrosis of an electrical conduction pathway in at least one of the esophagus, the lower esophageal sphincter, and the cardia.

12. A method according to claim 1

wherein the expandable structure is a basket assembly comprising a first arm, a second arm, and a third arm coupled together.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2008
From: RESPIRATORY DIAGNOSTIC, INC.
To: MEDERI THERAPEUTICS, INC.
Reel/Frame 022047/0503 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2008
From: CURON MEDICAL, INC. BY JOHN T. KENDALL, TRUSTEE
To: RESPIRATORY DIAGNOSTIC, INC.
Reel/Frame 020986/0312 →